Dana Carroll, PhD, MPH

Assistant Professor, Division of Environmental Health Sciences

Dana Carroll

Contact Info


Office Phone 612-624-0132

Office Address:
Mayo, 1232

Mailing Address:
Envrn Health Sciences (SPH)
MMC 807 Mayo
8807A (Campus Delivery Code)
420 Delaware St SE
Minneapolis, MN 55455

PhD, Epidemiology, University of Oklahoma Health Sciences Center, 2017

MPH, Epidemiology, Kent State University, 2013

BS, Molecular Genetics, The Ohio State University, 2011


I am an epidemiologist and certified tobacco treatment specialist committed to achieving health equity through reducing commercial tobacco use. My research spans a continuum from analyses of large epidemiologic surveys to clinical trials and community-based participatory research. Over the past several years I have had the opportunity to collaborate with Tribal nations and community organizations serving American Indian persons on projects examining susceptibility to cigarette smoking and lung cancer. More recently I have been utilizing mixed methods to help elevate the rich knowledge and expertise of American Indian persons and develop culturally tailored approaches to smoking cessation. My other, complementary, area of research entails studies that seek to inform product standards on commercial tobacco products. Within this area I am most interested in identifying how to reduce the appeal of cigarettes and have contributed to efforts demonstrating the potential public health impacts of reducing nicotine levels in cigarettes.


Epidemiological research methods; health disparities; tobacco prevention and control; tobacco regulatory science; biomarkers of tobacco use and cancer risk; community cancer prevention and control

Awards & Recognition

  • Delta Omega Honorary Society, Xi Chapter

Professional Associations

  • Society for Research on Nicotine and Tobacco


Research Funding Grants

  • 12/2021-11/2021, NIH/NIMHD R13 “National Tribal Tobacco Conference: Reclaiming and Restoring Traditional Tobacco in Today's World ", Co-Principal Investigator
  • 9/2021-8/2023, NIH/NCI R21 “Development and pilot testing of a culturally-tailored smartphone-delivered intervention for commercial smoking cessation in American Indians", Principal Investigator
  • 12/2020-12/2021, UMN Program Health Disparities Research and Masonic Cancer Center Pilot Grant Program "Utilizing traditional tobacco to reframe what tobacco is and is not to promote commercial smoking cessation in American Indians", Principal Investigator
  • 8/2020-2/2025, NIH/NIMHD K01 “Laying the Foundation for Personalized Smoking Cessation Treatment in the American Indian Population", Principal Investigator
  • 6/2020-5/2023, NIH/NIDA R01 “Impact of sugars on tobacco product toxicity and abuse liability", Co-Investigator 
  • 1/2020-1/2021, UMN/CENIC pilot projects program “ Impact of low nicotine educational messaging on smokers’ perceptions and behavior " Principal Investigator
  • 11/2019-08/2022, NIH/NCI P01 “Consortium on Methods Evaluating Tobacco (COMET): Filter Ventilation and Product Standards”, Co-Investigator
  • 11/2019-02/2022, NIH/NIDA U54 “Evaluating New Nicotine Standards for Cigarettes”, Co-Investigator
  • 6/2018-06/2019, NIH/NIDA T32 “Training in Neuroimmune/Neurobehavior Addiction Research”, Postdoctoral Trainee
  • 7/2016-6/2017, NIH/NIDA R36 “ Nicotine Metabolism in American Indian Tobacco and Electronic Cigarette Users " Principal Investigator   


  • Roland K, Anderson M, Carroll DM, Webber A, Rhodes K, Poupart J, Forster J, Peterson-Hickey M, and Pickner W. Tribal Tobacco Use Project II: Planning, Implementation, and Dissemination using Culturally Relevant Data Collection among American Indian Communities. Int. J. Environ. Res. Public Health 2022, 19(13), 7708.
  • Breland A, Carroll DM, Denlinger-Apte R, Cornacchione-Ross J, Soto C, White C, Donny E, Fagan P, Gardiner P, Eissenberg T, and Guy MC. Centering racial justice for Black/African American and Indigenous American people in commercial tobacco product regulation. Preventive Medicine
  • Differding M, Katz SJ, Strayer L, White C, Strasser A, Donny E, Hatsukami DK, Carroll, D.M. Educating the public on the health risks of very low nicotine content cigarettes: Results from a U.S.-based convenience sample. Nicotine Tob Res . 2022 Apr 28;24(6):871-880.
  • Denlinger-Apte RL, Pacek LR, Cornacchione Ross J, Bansal-Travers M , Donny EC, Hatsukami DK, and Carroll DM. Risk perceptions of low nicotine cigarettes and alternative nicotine products across priority smoking populations. Int J Environ Res Public Health. 2021 May 17;18(10):5311.
  • Carroll DM, Hernandez C, Braaten G, Meier E, Jacobson P, Begnaud A, McGonagle E, Frizzell LB, Hatsukami DK. Recommendations to researchers for increasing American Indian representation in genetic research and personalized medicine. Personalized Medicine, 2021 Jan;18(1):67-74.
  • Carroll DM, Stepanov I, O’Connor R, Luo X, Cummings M, Rees V, Bickel WK, Berman ML, Ashley D, Bansal-Travers M, Shields P, and Hatsukami DK. Impact of cigarette filter ventilation on U.S. smokers’ perceptions and biomarkers of exposure and potential harm. Cancer Epidemiol Biomarkers Prev. 2021 Jan;30(1):38-44
  • Hatsukami DK and Carroll DM. Tobacco Harm Reduction: Past History, Current Controversies, and a Proposed Approach for the Future. Preventive Medicine. 23 2020 April.
  • Carroll DM, Soto C, Baezconde-Garbanati L, Huang LL, Lienemann BA, Meissner HI, Rose SW, Unger JB, Cruz TB. Tobacco Industry Marketing Exposure and Commercial Tobacco Product Use Disparities among American Indians and Alaska Natives. Subst Use Misuse. 2019 Sep 23:1-10.
  • Carroll DM, Allenzara A, Jensen J, Stepanov I, Hecht S, Murphy S, Lou X, Donny E, and Hatsukami D. Biomarkers of Tobacco-Related Exposure and Potential among Cigarette Smokers of the Natural American Spirit Brand. Tobacco Regulatory Science. 2019, 5(4):339-351.
  • Carroll DM, Wagener TL, Peck JD, Brame LB, Thompson DM, Stephens LD, Campbell JE, Beebe LA. Biomarkers of exposure in ENDS users, smokers, and dual users of American Indian descent. Tob Regul Sci. 2018, 4(2):3-15.

Community Engagement

I strongly believe that everyone should be talking about health disparities. There is often a large gap between academy and the communities that are most in need. For this reason, I strive to engage and build relationships rooted in trust and cultural humility with American Indian tribes and other health disparity populations throughout my research.